lurasidone hydrochloride

FDA Drug Profile — Latuda, lurasidone hydrochloride

lurasidone hydrochloride is listed in the FDA National Drug Code directory with 59 NDC codes, marketed under brand names including Latuda, lurasidone hydrochloride. Available dosage forms: tablet, film coated, tablet, powder.

Drug details

Generic Name
lurasidone hydrochloride
Brand Names
Latuda, lurasidone hydrochloride
Application Number
NDA200603
Sponsor
Sumitomo Pharma America, Inc.
NDC Codes
59
Dosage Forms
TABLET, FILM COATED, TABLET, POWDER
Routes
ORAL
Active Ingredients
LURASIDONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Lurasidone hydrochloride tablets are indicated for: • Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies ( 14.2 )]. • Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies ( 14.2 )]. Lurasidone hydrochloride tablets are an atypical antipsychotic indicated for the treatment of: • Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy ( 1 , 14.2 ) • Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate ( 1, 14.2 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.